Okamoto T, Goto S
Department of Obstetrics and Gynecology, Chukyo Hospital, Nagoya, Japan.
Gynecol Obstet Invest. 2001;52(2):139-41. doi: 10.1159/000052959.
Most patients with gestational trophoblastic disease in whom single-agent or even combination chemotherapy has failed can be cured with salvage chemotherapy including etoposide or platinum-based regimens. Here we report a rare case of uterine choriocarcinoma following a molar evacuation that seemed to develop during chronic low-dose oral administration of etoposide for approximately 16 months. Although the patient was expected to have a good chance of cure using combination chemotherapy, the lesion was resistant to multiple-agent chemotherapy including cisplatin.